NCT07214571: A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
- State
- Under way
- Phase
- Phase 2
- People
- 192 planned
- Started
- 11 Dec 2025
- Primary completion
- 30 Dec 2026
- Arms
- S-337395 High Dose, S-337395 Low Dose
- Results
- None posted
- 9 Oct 2025: Trial registered
- 11 Dec 2025: Trial started